BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghafouri-Fard S, Shirvani-Farsani Z, Branicki W, Taheri M. MicroRNA Signature in Renal Cell Carcinoma. Front Oncol 2020;10:596359. [PMID: 33330087 DOI: 10.3389/fonc.2020.596359] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hoshino I. The usefulness of microRNA in urine and saliva as a biomarker of gastroenterological cancer. Int J Clin Oncol 2021;26:1431-40. [PMID: 33835295 DOI: 10.1007/s10147-021-01911-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Pinto PC, Rönnau C, Burchardt M, Wolff I. Kidney Cancer and Chronic Kidney Disease: Too Close for Comfort. Biomedicines 2021;9:1761. [PMID: 34944574 DOI: 10.3390/biomedicines9121761] [Reference Citation Analysis]
3 Olmedo-suárez MÁ, Ramírez-díaz I, Pérez-gonzález A, Molina-herrera A, Coral-garcía MÁ, Lobato S, Sarvari P, Barreto G, Rubio K. Epigenetic Regulation in Exposome-Induced Tumorigenesis: Emerging Roles of ncRNAs. Biomolecules 2022;12:513. [DOI: 10.3390/biom12040513] [Reference Citation Analysis]
4 Tito C, De Falco E, Rosa P, Iaiza A, Fazi F, Petrozza V, Calogero A. Circulating microRNAs from the Molecular Mechanisms to Clinical Biomarkers: A Focus on the Clear Cell Renal Cell Carcinoma. Genes (Basel) 2021;12:1154. [PMID: 34440329 DOI: 10.3390/genes12081154] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xu C, Zeng H, Fan J, Huang W, Yu X, Li S, Wang F, Long X. A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09322-9] [Reference Citation Analysis]
6 Pei L, Lv X, Jia G, Tan X, Li M, Zhang A. Silencing circular RNA circ_0054537 and upregulating microRNA-640 suppress malignant progression of renal cell carcinoma via regulating neuronal pentraxin-2 (NPTX2). Bioengineered 2021;12:8279-95. [PMID: 34565284 DOI: 10.1080/21655979.2021.1984002] [Reference Citation Analysis]
7 Scholtes MP, Alberts AR, Iflé IG, Verhagen PCMS, van der Veldt AAM, Zuiverloon TCM. Biomarker-Oriented Therapy in Bladder and Renal Cancer. Int J Mol Sci 2021;22:2832. [PMID: 33799514 DOI: 10.3390/ijms22062832] [Cited by in F6Publishing: 1] [Reference Citation Analysis]